Browsing by Author "Pekcan, Sevgi"
Now showing items 1-10 of 10
-
CFTR mutations unidentified in CFTR2 database and their phenotypic characteristics: Data from cystic fibrosis registry of Turkey
Cinel, Guzin; Dogru, Deniz; Cakir, Erkan; Eyuboglu, Tugba Sismanlar; Cobanoglu, Nazan; Pekcan, Sevgi; Yalcin, Ebru (European Respiratory Soc Journals Ltd, 2020)[Abstract Not Available] -
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis
Şişmanlar Eyüboğlu, Tuğba; Doğru, Deniz; Çakır, Erkan; Çobanoğlu, Nazan; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu (Wiley, 2020)Background Pseudo-Bartter syndrome (PBS) is a rare complication of cystic fibrosis (CF) and there are limited data in the literature about it. We aimed to compare clinical features and accompanying findings of patients ... -
Comparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war
Yılmaz, Aslı İmran; Pekcan, Sevgi; Eyüboğlu, Tuğba Şişmanlar; Hangül, Melih; Arslan, Hüseyin; Kılınç, Ayşe Ayzit; Çokuğraş, Haluk (Springer, 2024)Since the outbreak of the Syrian civil war in 2011, the population of Arab refugees in Turkey has rapidly increased. While cystic fibrosis (CF) is believed to be rare among Arabs, recent studies suggest it is underdiagnosed. ... -
Cystic fibrosis in Turkey: First data from the national registry
Doğru, Deniz; Çakır, Erkan; Şişmanlar, Tuğba; Çobanoğlu, Nazan; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice S. (Wiley, 2020)Background Cystic fibrosis (CF) care has been implemented in Turkey for a long time; however, there had been no patient registry. For this purpose, the Turkish National CF Registry was established. We present the first ... -
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Cobanoglu, Fatma Nazan; Ersoz, Deniz Dogru; Cakir, Erkan; Eyuboglu, Tugba Sismanlar; Pekcan, Sevgi; Cinel, Guzin; Yalcin, Ebru (European Respiratory Soc Journals Ltd, 2019)[Abstract Not Available] -
Geographical barriers to timely diagnosis of cystic fibrosis and anxiety level of parents during newborn screening in Turkey
Gökdemir, Yasemin; Eyüboğlu, Tuğba Şişmanlar; Emiralioğlu, Nagehan; Er, Berrin; Şen, Velat; Pekcan, Sevgi; Ergenekon, Almala Pınar (Wiley, 2021)Background Despite the availability of cystic fibrosis (CF) screening countrywide, diagnostic delay is still a crucial issue. The objectives of this study were to explore the stages of the NBS process, determine the risk ... -
Hospital-based multicenter study in Turkey: The atopic effect on the progress of viral pneumonia
Bahceci, Semiha; Can, Demet; Girit, Saniye; Catal, Ferhat; Sen, Velat; Pekcan, Sevgi; Yuksel, Hasan (European Respiratory Soc Journals Ltd, 2015)[Abstract Not Available] -
Modulatory therapy experience in patients with cystic fibrosis in Turkey: A multi-center study
Ergenekon, Pinar; Eralp, Ela Erdem; Sakalli, Ayse Ayzit Kilinc; Yanaz, Muruvvet; Baskan, Azer Kilic; Gulieva, Aynur; Pekcan, Sevgi (European Respiratory Soc Journals Ltd, 2023)[Abstract Not Available] -
Multicentric analysis of childhood tuberculosis in Turkey
Pekcan, Sevgi; Aslan, Ayse Tana; Kiper, Nural; Uysal, Gulnar; Gurkan, Fuat; Patiroglu, Turkan; Ozturk, Mustafa (Turkish J Pediatrics, 2013)Only a few series of pediatric tuberculosis (TB) have been reported in the last 20 years. The purpose of this study was to evaluate the clinical, radiological, microbiological, and treatment characteristics of childhood ... -
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Çobanoğlu, Nazan; Özçelik, Uğur; Çakır, Erkan; Eyüboğlu, Tuğba Şişmanlar; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Şen, Velat; Şen, Hadice Selimoğlu (Wiley, 2020)Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacafto ...
